SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1427Any breakdown, US vs ROW? Still no guidance on when or if they'll file in thrkrw-10/31/2007
14263Q07 Lovenox sales +13% to €633 million ($914M).DewDiligence_on_SI-10/31/2007
1425From Teva's CC: This was also an excellent quarter for our innovative businIRWIN JAMES FRANKEL-10/30/2007
1424Groovy new board member. Momenta Pharmaceuticals Announces Appointment of Elizrkrw-10/30/2007
1423That may explain it - timing is about right. ijIRWIN JAMES FRANKEL-10/24/2007
1422Thanks IJ. Related to new FTD rules? JonRobohogs-10/24/2007
1421Big news, IMO, but why posted on the MNTA board?DewDiligence_on_SI-10/24/2007
1420Lilly stops small prasugrel trials of heart patients Wed Oct 24, 2007 5:00pm EDTrkrw-10/24/2007
1419SI 8,066,905 down in two weeks from 8,963,497, a decline of 897,592. That amounIRWIN JAMES FRANKEL-10/24/2007
1418Expecting oral argument in December but so far the case (Aventis v. Amphastar, 0IRWIN JAMES FRANKEL-10/24/2007
1417Sanofi Seeks Takeovers to Beat Looming Sales Decline (Update3) By Angela CullenIRWIN JAMES FRANKEL-10/20/2007
1416Of course. Copaxone has been around forever. Without having to know a thing, I drkrw-10/16/2007
1415<i>I don't think its unreasonable to think copaxone could at least be DewDiligence_on_SI-10/16/2007
1414There was one more important Copaxone trial presented at ECTRIMS: "The impidos-10/16/2007
1413Makes sense to me. I don't think its unreasonable to think copaxone could atrkrw-10/16/2007
1412Did you see the REGARD study presented at ECTRIMS? In it, Rebif failed to demontuck-10/16/2007
141115-Oct-07 12:10 ET IRWIN JAMES FRANKEL-10/15/2007
1410The Jan 08 options have been much richer for a while now vs. the Dec 07s. If thRobohogs-10/12/2007
1409The rationale for BSC's theory that the FDA won't rule until the judges tuck-10/12/2007
1408Stanford Group out yesterday or today saying not happy with M118 trials as compaRobohogs-10/12/2007
1407Their initiation report at hold read like a short report. Tone is not actually mRobohogs-10/12/2007
1406And what might be presumed to be BSC's latest insight? Care to guess? I haquidditch-10/12/2007
1405BSC downgrades to underperfrom from peer performIRWIN JAMES FRANKEL-10/12/2007
1404Stable angina and ACS have evidently been flip-flopped: the latter was originallDewDiligence_on_SI-10/11/2007
1403Momenta Pharmaceuticals Initiates Phase 2 Study of Novel Anticoagulant M118 OngoIRWIN JAMES FRANKEL-10/11/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News